Bath & Body Works Inc. (NYSE: BBWI) saw its stock plummet 6.08% in pre-market trading on Thursday, as investors brace for the company's third-quarter earnings report scheduled to be released before the opening bell. The sharp decline comes amid mixed analyst sentiment and expectations of lower earnings compared to the previous year.

Analysts are projecting Bath & Body Works to report quarterly earnings of 40 cents per share, down from 49 cents per share in the same period last year. The consensus estimate for the company's quarterly revenue stands at $1.63 billion, slightly higher than the $1.61 billion reported a year ago. These expectations suggest potential pressure on the company's profitability despite a modest increase in sales.

Recent analyst ratings reflect a cautious outlook on Bath & Body Works' stock. While some analysts maintain positive ratings, others have downgraded or lowered their price targets. Notably, Raymond James downgraded the stock from Outperform to Market Perform on November 12, signaling reduced confidence in the company's near-term prospects. However, Morgan Stanley and Wells Fargo have maintained their Overweight ratings, albeit with mixed adjustments to their price targets.

The pre-market plunge indicates that investors may be positioning themselves defensively ahead of the earnings release, possibly due to concerns about the company's performance in a challenging retail environment. As the market awaits the official earnings report, all eyes will be on Bath & Body Works' ability to navigate current economic headwinds and maintain its market position in the competitive personal care and home fragrance sectors.